CenExel Acquires ForCare Clinical Research
August 4, 2021
CenExel Clinical Research has acquired Tampa-based ForCare Clinical Research, adding a dermatology- and immunology-focused clinical research site to its Centers of Excellence network. The addition strengthens CenExel's capabilities to conduct Phase I–IV trials across dermatology, immunology and other therapeutic areas and will integrate ForCare into CenExel's centralized operations and quality systems. Provident Healthcare Partners served as exclusive sell-side financial advisor to ForCare in the transaction.
- Targets
- ForCare Clinical Research
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Flourish Research Acquires Center for Advanced Research & Education (CARE)
May 7, 2025
Healthcare Services
Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina, acquired the Center for Advanced Research & Education (CARE), a Gainesville, Georgia-based clinical research facility. The deal expands Flourish's geographic footprint into the Southeast, strengthens its oncology capabilities, and deepens relationships with pharmaceutical sponsor clients.
-
BayPine to Acquire CenExel Clinical Research
April 14, 2025
Healthcare Services
BayPine entered into a definitive agreement to acquire CenExel Clinical Research, a nationwide clinical trial site network focused on complex therapeutic areas. After closing, BayPine will be the majority investor in CenExel alongside Webster Equity Partners, which will retain a minority stake, with management continuing to hold equity.
-
CenExel Acquires iResearch
May 3, 2022
Healthcare Services
CenExel, a Salt Lake City–based clinical research site network, acquired iResearch, a multi-specialty clinical research site with locations in Decatur and Savannah, Georgia. The deal strengthens CenExel's CNS (psychiatry and neurology) and dermatology trial capabilities while expanding its patient reach in the Atlanta metro and throughout Georgia.
-
CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center
January 11, 2022
Healthcare Services
CenExel Clinical Research, Inc. acquired the clinical research site operations of Rocky Mountain Movement Disorders Center (now CenExel RMCR), expanding CenExel's neurology/CNS trial capabilities and site network. Objective, Investment Banking & Valuation acted as exclusive sell-side advisor to Rocky Mountain Movement Disorders Center and the transaction will allow the center to leverage CenExel's centralized processes and network.
-
CenExel Clinical Research Acquires California Neuroscience Research
January 10, 2022
Healthcare Services
CenExel Clinical Research, a Salt Lake City–based clinical research site network, has acquired California Neuroscience Research, a Los Angeles area neurology and psychiatry clinical research facility led by Dr. Tom Shiovitz. The acquisition strengthens CenExel's central nervous system (CNS) trial capabilities and expands its patient reach in the Los Angeles market.
-
CenExel Clinical Research Acquires CITrials
March 9, 2021
Healthcare Services
CenExel Clinical Research, a U.S.-based network of clinical research sites, has acquired CITrials, a Southern California clinical research firm operating three sites serving Los Angeles, Orange, and Riverside/San Bernardino counties. The acquisition expands CenExel's capacity and capabilities in psychiatric and neurological (CNS) research and enables greater integration with its other Southern California operations.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.